Home
Silverarc Capital Management reported a 4.9% stake in NextCure NXTC · 176,057 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.9%
- Last report
- 5.02% · filed 26/02/12
- Shares held
- 176,057 sh
- Class
- Class A Common Stock
- Stock
- NextCure NXTC
- Event date
- 26/03/31
- Filed
- 26/05/13
4.9% stake · below 5%
- Stake
- 4.9%
- Last report
- 5.02%
- Since last report
- −0.1pp
NextCure trades, last 26 weeks
What else happened in NextCure around then
Filed or reported within 30 days of the trade day · 03/01~04/30Silverarc Capital Management's other 5% stake reports
- Silverarc Capital Management
5% stakeCellectar Biosciences
5% stakeCellectar Biosciences
CLRB
9.99% stake
851,285 sh
9.99% stake
Filed 08/14
- Silverarc Capital Management
5% stakeTela Bio
5% stakeTela Bio
TELA
4.8% stake
2,137,201 sh
4.8% stake
Filed 08/11
- Silverarc Capital Management
5% stakeElutia
5% stakeElutia
ELUT
4.9% stake
2,192,980 sh
4.9% stake
Filed 08/11
- Silverarc Capital Management
5% stakeHelix Acquisition Corp. III
5% stakeHelix Acquisition Corp. III
HLXC
6.8% stake
1,208,986 sh
6.8% stake
Filed 05/13
- Silverarc Capital Management
5% stakeFractyl Health
5% stakeFractyl Health
GUTS
2.3% stake
3,606,386 sh
2.3% stake
Filed 05/13
